<DOC>
	<DOCNO>NCT00634972</DOCNO>
	<brief_summary>The purpose study test whether ACULAR , nonsteroidal anti-inflammatory eye drop medication , prevent development retinopathy prematurity ( ROP ) and/ decrease severity.In study ACULAR compare placebo ( artificial tear ) . The hypothesis would ACULAR treatment decrease incidence moderate severe ROP ( grade II ) 50 % .</brief_summary>
	<brief_title>Efficient Study ACULAR Inhibiting Proliferative Retinopathy Prematurity</brief_title>
	<detailed_description>Each year ROP affect estimate 14,000-16,000 premature , low birth weight infant United States thousand worldwide , make leading cause vision loss child . Of case , approximately 1500 infant develop severe ROP require surgical treatment . Despite treatment , 400-600 infant severe ROP still become legally blind year . ACULARÂ® ( Ketorolac eye drop ) member nonsteroidal anti-inflammatory drug ( NSAIDs ) available toipcal ocular use . ACULAR act prostaglandin inhibitor decrease prostaglandin E2 production . An increase prostaglandin production associate various inflammatory eye disease.For instance ACULAR show effective prevent post cataract surgery inflammation result macular edema adult . Activation prostaglandin cascade demonstrate animal model ROP . A previous non randomize study use ACULAR ROP prevention show possible beneficial effect observe adverse effect . To clearly demonstrated confirm find randomize study thus necessary one advocate use prevention ROP.The medication FDA approve pediatrics allergic conjunctivitis post surgical ocular inflammation .</detailed_description>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Retinal Detachment</mesh_term>
	<mesh_term>Blindness</mesh_term>
	<mesh_term>Retinopathy Prematurity</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<criteria>All preterm infant gestational age less equal 28 week complete gestational age 10 15 day postnatal age admit regional NICU</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>15 Days</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Retinopathy Prematurity</keyword>
	<keyword>Premature Infants</keyword>
	<keyword>ACULAR</keyword>
	<keyword>Refresh Tears</keyword>
</DOC>